ECONOMIC EVALUATIONS IN RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): CHALLENGES FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS

被引：0
|
作者：
Forbes, C. [1 ]
Pustulka, I [2 ]
Zuchinali, P. [3 ]
Kumar, J. [4 ]
机构：
[1] Evidera PPD, London, England
[2] Evidera PPD, Warsaw, Poland
[3] Evidera PPD, Montreal, PQ, Canada
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA83
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [1] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
  • [2] THE CURE MYTH: EXPERIENCE FROM RECENT HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
    Mohseninejad, L.
    Hardy, A.
    Westley, T.
    Kongnakorn, T.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S8 - S8
  • [3] HUMANISTIC BURDEN IN RELAPSED OR REFRACTORY (R/ R) FOLLICULAR LYMPHOMA (FL): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Forbes, C.
    Pustulka, I
    Nunez-Gonzalez, S.
    Kumar, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S451 - S452
  • [4] Real-world early outcomes of axicabtagene ciloleucel for relapsed or refractory (R/R) follicular lymphoma (FL).
    Jacobson, Caron Alyce
    Hemmer, Michael T.
    Hu, Zhen-Huan
    Frank, Matthew Joshua
    Popplewell, Leslie
    Ahmed, Nausheen
    Lin, Yi
    Best, Timothy
    Beygi, Sara
    Miao, Harry H.
    Fu, Christine
    Sun, Fang
    Xu, Hairong
    Pasquini, Marcelo C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China
    Song, Yuqin
    Ying, Zhitao
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Wu, Jianqiu
    Yang, Su
    Zhang, Pian
    Ma, Meilin
    Zhou, Zisong
    Zheng, Hongxia
    Zhu, Jun
    [J]. BLOOD, 2021, 138
  • [6] Efficacy Outcomes of Treatments for Double Relapsed/Refractory Follicular Lymphoma (R/R FL): A Systematic Literature Review
    Kahl, Brad S.
    Patel, Anik R.
    Zaidi, Omer
    Snedecor, Sonya J.
    Purdum, Anna G.
    [J]. BLOOD, 2020, 136
  • [7] DIFFERENT APPROACHES TO THE HEALTH ECONOMIC EVALUATIONS FOR THE HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS
    Smela, B.
    Toumi, M.
    Swierk, K.
    Millier, A.
    Boyer, L.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S343 - S344
  • [8] Results of the PI3Kδ inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL).
    Zelenetz, Andrew David
    Jagadeesh, Deepa
    Reddy, Nishitha M.
    Stathis, Anastasios
    Salman, Huda S.
    Asch, Adam Steven
    Kenkre, Vaishalee Padgaonkar
    Jhangiani, Haresh S.
    Iasonos, Alexia
    Soumerai, Jacob D.
    Llorin, Judith
    Pagel, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.
    Leppa, Sirpa
    Santoro, Armando
    Demeter, Judit
    Follows, George
    Lenz, Georg
    Kim, Won Seog
    Mollica, Luigina
    Nagler, Arnon
    Diong, Colin Phipps
    Provencio, Mariano
    Stevens, Don A.
    Trevarthen, David R.
    Wang, MingLu
    Wirtz, Oliver
    Miriyala, Ashok
    Vargas, Jose Garcia
    Childs, Barrett H.
    Zinzani, Pier Luigi
    Dreyling, Martin H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL)
    Schuster, Stephen J.
    Dickinson, Michael
    Dreyling, Martin
    Martinez-Lopez, Joaquin
    Kolstad, Arne
    Butler, Jason
    Ghosh, Monalisa
    Popplewell, Leslie
    Chavez, Julio C.
    Bachy, Emmanuel
    Kato, Koji
    Harigae, Hideo
    Kersten, Marie Jose
    Andreadis, Charalambos
    Riedell, Peter
    Zia, Aiesha
    Morisse, Mony Chenda
    Fowler, Nathan Hale
    Thieblemont, Catherine
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S403 - S404
12345